Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05652114 · ClinicalTrials.gov registry record · NA
Open Label Mightier Play in the Home
A NA study of Emotional Regulation, sponsored by Neuromotion Labs.
- Completed
- Registry status
- NA
- Development phase
- 2,732
- Enrollment target
- 1
- Study location
NCT05652114: Completed NA study of Emotional Regulation, sponsored by Neuromotion Labs.
NCT05652114 is a NA study of Emotional Regulation that has completed, run by Neuromotion Labs. The registered enrollment target is 2,732 participants, above the 229-participant average among 11 other Emotional Regulation trials with a reported enrollment target (1093% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05652114, a NA study of Emotional Regulation, has completed, sponsored by Neuromotion Labs.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,732 participants
- Enrollment target
- 1
- Study location
Study Summary
Mightier is a digital mental health tool that uses video game-based heart rate biofeedback to teach emotion regulation. The primary goal of this study is to replicate results from original clinical trials, demonstrating that playing Mightier at home improves common symptoms associated with emotional dysregulation. Participants will be caregivers of children who are using Mightier, a video-game based heart rate biofeedback intervention. Caregivers will be asked to complete a short survey about their child's emotions and behaviors prior to their child's first play and then complete that survey two more times, at 8 weeks and 12 weeks post baseline. The pre-post self report design will allow us to observe changes during Mightier use and relate those changes to overall engagement with the intervention
Primary Outcome
The Affective Reactivity Index is a 7 item parent reported measure of irritability. Scores range from 0-12, with higher scores representing greater irritability.
Conditions Studied
Interventions
- BEHAVIORAL Mightier
Study Locations (1)
Massachusetts
- Neuromotion Inc - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,732 participants |
| Start Date | 2020-04-10 |
| Est. Completion | 2022-11-17 |
| Phase | NA |
What the finished NCT05652114 record still lists
NCT05652114 is an interventional study that assigns participants to a tested intervention. Its 2,732 participants enrollment target places it among the larger protocols in the corpus, above the 229-participant average among 11 other Emotional Regulation trials with a reported enrollment target (1093% higher).
The record links to 1 condition, with Emotional Regulation appearing as the primary indexed condition, and to 1 intervention - of which Mightier is the first listed.
NCT05652114 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05652114 about?
NCT05652114 is a clinical study titled "Open Label Mightier Play in the Home". Mightier is a digital mental health tool that uses video game-based heart rate biofeedback to teach emotion regulation. The primary goal of this study is to replicate results from original clinical trials, demonstrating that playing Mightier at home improves common symptoms associated with emotional...
What is the current status of trial NCT05652114?
This trial is currently completed. It is a NA study. The enrollment target is 2,732 participants. The study started on 2020-04-10. Estimated completion is 2022-11-17.
What conditions does trial NCT05652114 study?
This clinical trial studies the following conditions: Emotional Regulation.
What interventions are being tested in trial NCT05652114?
The interventions under investigation include: Mightier (BEHAVIORAL).
Who is sponsoring clinical trial NCT05652114?
This trial is sponsored by Neuromotion Labs, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05652114 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Emotional Regulation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05652114's enrollment target sits among peer trials
2,732 1st of 11 higher than 11 of 11 other Emotional Regulation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Emotional Regulation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluation of the Parenting in the Moment Online Program for Forcibly Displaced Families
RECRUITING · NA
-
Students With Involved Families and Teachers
RECRUITING · NA
-
The STRENGTHEN Study
RECRUITING · NA
-
Improving Minority Health Through Biofeedback and Stress Reduction
RECRUITING · NA
-
An Intervention to Enhance Well-Being in Trauma Exposed New Mothers
ACTIVE NOT RECRUITING · NA
-
An Adjunctive Neurofeedback Training Program to Enhance Wellness Among Trauma-Exposed Postpartum Mothers
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06085833 · 2,706 participants · NA
ARTIDIS Nanomechanical Generated Measurements for Early Breast Lesions
- NCT04073420 · 2,700 participants
Medtronic Cardiac Surgery PMCF Registry
- NCT05125939 · 2,700 participants
Can Overall Adenoma Detection Rate Replace Screening Adenoma Detection Rate ? Multicenter Study
- NCT05586776 · 2,700 participants · Phase 4
Decolonization to Reduce After-Surgery Events of Surgical Site Infection
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI